Clinical Trials > Head and Neck > SAVER

  • Information
  • Sites - Interested
SAVER

Title

Sodium Valproate for Epigenetic Re-programming in Management of High Risk Oral Epithelial Dysplasia: a randomised, double blind, placebo controlled clinical trial with embedded mechanistic and feasibility studies.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
II Open The University of Liverpool EUDRACT No: 2018-000197-30
ISRCTN No:
5

Purpose


Trial Lead Organisations


Official Title

Sodium Valproate for Epigenetic Re-programming in Management of High Risk Oral Epithelial Dysplasia: a randomised, double blind, placebo controlled clinical trial with embedded mechanistic and feasibility studies.


Trial Start Date

24/09/2019


References


Trial Coordinator

Binyam Tesfaye


Trial Coordinator Email Address

btesfaye@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 7328



UK: SCOTLAND

  • Glasgow, Queen Elizabeth University Hospital (James McCaul)

Login

Username:
Password:

Lost Username / Password?